Proteovant Therapeutics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.proteovant.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Proteovant Therapeutics
Proteovant is leveraging the process of protein degradation to discover and develop transformative medicines for the treatment of patients with life-altering diseases. Protein degradation harnesses the human body's innate cellular machinery by way of the ubiquitin proteasome system (UPS) to identify and mark disease causing proteins for destruction. This promising approach provides the opportunity to target proteins of interest, many of which were previously considered undruggable. Proteovant integrates its foundational degrader portfolio, internal deep drug hunting expertise, and VantAI's proprietary 'Protein Contact First' deep learning platform to advance novel protein degraders across a range of therapeutic areas. Founding investors include Roivant Sciences and SK Inc.Explore more
Proteovant Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Proteovant Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Proteovant Therapeutics is spiking on competitors!
Check if Proteovant Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Proteovant Therapeutics has new funding data
Earning: See what the market has to say on Proteovant Therapeutics recently announced quarterly report
Click to see if Proteovant Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Proteovant Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Proteovant Therapeutics
Website visits: Recent activity has been detected on your website
Proteovant Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Proteovant Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Proteovant Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Proteovant Therapeutics.
Proteovant Therapeutics Tech Stack
A closer look at the technologies used by Proteovant Therapeutics
Proteovant Therapeutics News & Media
SK Biopharmaceuticals’ Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference
These are the first in a series of presentations scheduled through the end of the year sharing advances to SK Biopharmaceutical’s targeted protein degradation (TPD) pipeline These are the first in a series of presentations scheduled through the end of the year sharing advances to SK Biopharmaceutical’s targeted protein degradation (TPD) pipelineProteovant Therapeutics to Present Preclinical Data from Estrogen Receptor and IKZF2 Protein Degrader Programs
PVTX-321 and PVTX-405 Achieve Development Candidate Nomination PVTX-321 and PVTX-405 Achieve Development Candidate NominationBlueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies
CAMBRIDGE, Mass., Feb. 28, 2022 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) and Proteovant Therapeutics today announced a strategic collaboration to advance novel targeted protein degrader therapies to address important areas of medical need. Targeted protein...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Proteovant Therapeutics
Sign Up For FreeTo access detailed company insights
Proteovant is leveraging the process of protein degradation to discover and develop transformative medicines for the treatment of patients with life-altering diseases. Protein degradation harnesses the human body's innate cellular machinery by way of the ubiquitin proteasome system (UPS) to identify and mark disease causing proteins for destruction... Read More
